SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-24-026050
Filing Date
2024-02-21
Accepted
2024-02-21 16:21:27
Documents
1
Group Members
GARY RIESCHELMARK MCDADEQIMING U.S. HEALTHCARE FUND II, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm246806d1_sc13da.htm SC 13D/A 72095
  Complete submission text file 0001104659-24-026050.txt   73764
Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Subject) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92771 | Film No.: 24659859
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 11100 NE 8TH ST, SUITE 200 BELLEVUE WA 98004
Business Address 11100 NE 8TH ST, SUITE 200 BELLEVUE WA 98004 425-709-0772
Qiming U.S. Healthcare GP II, LLC (Filed by) CIK: 0001868862 (see all company filings)

IRS No.: 833293758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A